Microbix Biosystems Statistics
Total Valuation
MBXBF has a market cap or net worth of 36.29 million. The enterprise value is 31.57 million.
| Market Cap | 36.29M |
| Enterprise Value | 31.57M |
Important Dates
The last earnings date was Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 140.83M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.43% |
| Shares Change (QoQ) | -1.10% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 118.42M |
Valuation Ratios
The trailing PE ratio is 27.17.
| PE Ratio | 27.17 |
| Forward PE | n/a |
| PS Ratio | 2.27 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | 26.13 |
| P/OCF Ratio | 13.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.75, with an EV/FCF ratio of 22.72.
| EV / Earnings | 23.63 |
| EV / Sales | 1.91 |
| EV / EBITDA | 11.75 |
| EV / EBIT | 19.13 |
| EV / FCF | 22.72 |
Financial Position
The company has a current ratio of 6.62, with a Debt / Equity ratio of 0.22.
| Current Ratio | 6.62 |
| Quick Ratio | 4.64 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.72 |
| Debt / FCF | 3.22 |
| Interest Coverage | 2.50 |
Financial Efficiency
Return on equity (ROE) is 6.85% and return on invested capital (ROIC) is 4.16%.
| Return on Equity (ROE) | 6.85% |
| Return on Assets (ROA) | 3.79% |
| Return on Invested Capital (ROIC) | 4.16% |
| Return on Capital Employed (ROCE) | 6.51% |
| Revenue Per Employee | 160,061 |
| Profits Per Employee | 13,356 |
| Employee Count | 100 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.16% in the last 52 weeks. The beta is 0.29, so MBXBF's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +6.16% |
| 50-Day Moving Average | 0.27 |
| 200-Day Moving Average | 0.27 |
| Relative Strength Index (RSI) | 46.16 |
| Average Volume (20 Days) | 47,495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MBXBF had revenue of 16.01 million and earned 1.34 million in profits. Earnings per share was 0.01.
| Revenue | 16.01M |
| Gross Profit | 8.98M |
| Operating Income | 1.60M |
| Pretax Income | 1.44M |
| Net Income | 1.34M |
| EBITDA | 2.49M |
| EBIT | 1.60M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 9.07 million in cash and 4.48 million in debt, giving a net cash position of 4.59 million.
| Cash & Cash Equivalents | 9.07M |
| Total Debt | 4.48M |
| Net Cash | 4.59M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 20.09M |
| Book Value Per Share | 0.15 |
| Working Capital | 15.16M |
Cash Flow
In the last 12 months, operating cash flow was 2.64 million and capital expenditures -1.25 million, giving a free cash flow of 1.39 million.
| Operating Cash Flow | 2.64M |
| Capital Expenditures | -1.25M |
| Free Cash Flow | 1.39M |
| FCF Per Share | n/a |
Margins
Gross margin is 56.11%, with operating and profit margins of 10.01% and 8.34%.
| Gross Margin | 56.11% |
| Operating Margin | 10.01% |
| Pretax Margin | 9.00% |
| Profit Margin | 8.34% |
| EBITDA Margin | 15.53% |
| EBIT Margin | 10.01% |
| FCF Margin | 8.68% |
Dividends & Yields
MBXBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.43% |
| Shareholder Yield | 0.43% |
| Earnings Yield | 3.68% |
| FCF Yield | 3.83% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MBXBF has an Altman Z-Score of 3.05.
| Altman Z-Score | 3.05 |
| Piotroski F-Score | n/a |